Found 113 articles for: "acne"
Early Acne Improvements With Fixed-Combination Topical Therapy: Analysis of the First 4 Weeks of Treatment
January 2025 | Volume 24 | Issue 1 | Journal Article | 79 | Copyright © January 2025
Background: Acne treatment can take weeks to deliver noticeable improvements, which may diminish patients’ perception of treatment effectiveness and undermine treatment adh...
Read MoreUtility of Adding Platelet-Rich Plasma to Microneedling vs Microneedling Alone in the Treatment of Acne Scarring
January 2025 | Volume 24 | Issue 1 | Journal Article | 41 | Copyright © January 2025
Acne vulgaris is one of the most common skin diseases worldwide and affects a large population of patients. Post-acne scarring can pose a significant psychosocial burden on patients of all ages; ...
Read MoreIntegrating Dermocosmetic Therapy for Acne: Addressing Severity Levels in Real-Life Experiences
January 2025 | Volume 24 | Issue 1 | Journal Article | 88 | Copyright © January 2025
Background: Acne is prevalent in approximately 80% of individuals aged 11 to 30 years, with scarring occurring in about 40% of cases. Early and sustained treatment is crucial for...
Read MoreLaser and Energy Treatments for Acne Scarring: A Review of Clinical Trials
December 2024 | Volume 23 | Issue 12 | Original Article | 1058 | Copyright © December 2024
Background: Acne scarring can have a detrimental impact on quality of life, making early and effective treatment essential. Lasers and energy-based treatment are the preferred tr...
Read MoreEffective With Minimal Side Effects: A Novel Treatment Regimen for Acne Vulgaris Using Multifunctional Ingredients
December 2024 | Volume 23 | Issue 12 | Original Article | 1042 | Copyright © December 2024
Background: There are numerous over-the-counter products for treating acne, although many formulations have tolerability issues and lack the cosmetic elegance desired by adult pa...
Read MoreTriple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne in Children and Adolescents
December 2024 | Volume 23 | Issue 12 | Original Article | 1049 | Copyright © December 2024
Background: Topical clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% (CAB) gel is the only fixed-dose triple-combination approved for acne (indicated in patients ...
Read MoreNovel Methods in Acne Treatment and Skin Care: A Review
December 2024 | Volume 23 | Issue 12 | Original Article | e181 | Copyright © December 2024
Background: Acne skin care aims to reduce the stratum corneum layer, normalization of sebum secretion, and mitigation of purulent lesions. Antibiotics, such as macrolides, clinda...
Read MoreClindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient Journey
November 2024 | Volume 23 | Issue 11 | Case Reports | 1017 | Copyright © November 2024
Introduction: Topical clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% (CAB) gel is the only fixed-dose, triple-combination formulation approved for acne treatmen...
Read MoreTreatment of Mild to Severe Acne Vulgaris With a 650-Microsecond 1064-nm Nd:YAG Laser
November 2024 | Volume 23 | Issue 11 | Original Article | 957 | Copyright © November 2024
Background: Effective treatment of acne remains a challenge to dermatologists.Objective: To evaluate the efficacy and tolerability of a 650-microsec...
Read MoreClindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Male and Female Acne: Phase 3 Analysis
October 2024 | Volume 23 | Issue 10 | Original Article | 873 | Copyright © October 2024
Background: Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel (CAB) is the only fixed-dose triple-combination treatment approved for acne. This post hoc analys...
Read MoreApplication Characteristics and Patient Preference of Triple-Combination vs Layered Topicals for Acne: Split-Face Study
October 2024 | Volume 23 | Issue 10 | Original Article | 857 | Copyright © October 2024
Background: Although triple-combination therapies for acne are generally more efficacious than dual-combinations or topical monotherapy, this benefit may be offset by reduced adh...
Read MoreTreatment of Acne Vulgaris-Associated Post-Inflammatory Dyschromia With Combination of Non-Ablative Laser Therapy and Topical Antioxidants
September 2024 | Volume 23 | Issue 9 | Original Article | 769 | Copyright © September 2024
Acne can cause disfiguring sequelae, such as scarring, post-inflammatory erythema (PIE), and post-inflammatory hyperpigmentation (PIH). These post-inflammatory dyschromias pose a significant psyc...
Read MoreTo Acne and Beyond: A Review of Sarecycline's Off-Label Uses
September 2024 | Volume 23 | Issue 9 | Features | 792 | Copyright © September 2024
NECASA I: A Practical Algorithm Integrating Skincare in the Management of Acne Patients in the Nordic European Countries
September 2024 | Volume 23 | Issue 9 | Original Article | 782 | Copyright © September 2024
Background: Acne vulgaris is a multifactorial dermatosis primary of the face and trunk. Erythema, pruritus, and xerosis are frequent adverse effects of first-line acne treatment ...
Read MoreUnited Arab Emirates Consensus Recommendations for Management of Acne Vulgaris
August 2024 | Volume 23 | Issue 8 | Original Article | 653 | Copyright © August 2024
Acne in the United Arab Emirates is a common disease that causes burden to patients, has psychosocial impacts, and is associated with physical sequelae such as dyspigmentation and scarring. This ...
Read MoreChallenges in Adult Acne and the Role of Skin Care in Managing the Condition
August 2024 | Volume 23 | Issue 8 | Original Article | 674 | Copyright © August 2024
Background: Acne vulgaris is a complex, multifactorial, inflammatory skin condition. Although frequently presented at dermatology clinics, the literature on adult acne is scarce,...
Read MoreAn Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color
June 2024 | Volume 23 | Issue 6 | Original Article | 410 | Copyright © June 2024
Introduction: Acne vulgaris is a common skin disease prevalent in skin of color patients. Studies have demonstrated that dapsone gel, 7.5% (Aczone) used once daily is effective, ...
Read MoreTriple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne in Adult and Pediatric Participants
June 2024 | Volume 23 | Issue 6 | Original Article | 394 | Copyright © June 2024
Background: Topical clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel (CAB) is the first fixed-dose triple-combination approved for the treatment of acne. This...
Read MoreInvestigating the Relationship Between Acne and Vasodilatory Medications in a Hospital-Wide Adult Population
June 2024 | Volume 23 | Issue 6 | Original Article | 446 | Copyright © June 2024
Acne vulgaris is a common chronic dermatological condition characterized by obstruction and inflammation of pilosebaceous units. Recent research on a different dermatologic condition has demonstr...
Read MoreTopical Clindamycin in the Management of Acne Vulgaris: Current Perspectives and Recent Therapeutic Advances
June 2024 | Volume 23 | Issue 6 | Original Article | 438 | Copyright © June 2024
© 2023 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
